UnitedHealth Group Incorporated

UNH Healthcare Healthcare Plans

UnitedHealth Group Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $447.6 billion, up 11.8% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 61.5%, free cash flow grew 62.7% and total debt fell 5.43%, each against the same quarter a year earlier. Member of the S&P 500 and Dow Jones; dividend growth for twenty-five consecutive years, revenue growth for ten.

377.76 0.76 −0.20%
Market cap
$339.1B
P/E
24.3×
Fwd P/E
23.3×
Dividend yield
2.40%
F-score
6/9
Altman Z
2.84
Beneish M
−2.41
Dividend safety
76/100
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
25.03 32.64 22.62 24.48 27.77 21.88 20.52 20.44 20.65 21.61
Piotroski F-Score
6 5 7 7 8 7 6 7 6 6
Altman Z-Score
2.84 3.48 3.78 3.91 4.21 3.60 3.61 3.73 3.61 3.25
P/S ratio
0.67 1.16 1.35 1.50 1.65 1.29 1.15 1.06 1.06 0.83
P/FCF ratio
18.65 22.50 19.49 20.76 23.81 16.54 17.06 17.58 18.42 19.00
Altman Z″-Score (non-manufacturers)
1.40 1.90 1.99 1.90 2.01 1.84 1.74 1.92 1.83 1.45
Beneish M-Score
(2.41) (2.37) (1.60) (2.89) (2.46) (2.53) (2.43) (2.45) (2.52) (2.42)
P/Operating CF
270.52 196.66 (96.38) (107.21) 147.15 54.55 45.06 100.13 (82.73) (109.08)
Dividend Safety Score
76 — — — — — — — — —
P/B ratio
2.99 4.74 5.30 5.97 6.31 4.87 4.63 4.42 4.28 4.03
Price to Tangible BV
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Sales
0.77 1.27 1.42 1.58 1.71 1.37 1.25 1.15 1.13 0.90
EV/EBITDA
14.75 13.99 14.56 16.10 18.17 13.90 13.49 13.16 12.98 11.09
EV/Operating CF
17.46 21.04 18.20 19.56 22.02 15.86 16.36 16.56 16.66 16.97
EV/FCF
21.40 24.59 20.60 21.90 24.74 17.48 18.43 19.06 19.58 20.54
Quick Ratio
0.70 0.75 0.69 0.51 0.66 0.62 0.58 0.61 0.62 0.59
Current Ratio
0.79 0.83 0.79 0.77 0.79 0.74 0.69 0.73 0.73 0.69
Net Debt/EBITDA
1.89 1.19 0.79 0.84 0.68 0.75 1.01 1.02 0.76 0.83
Debt/Assets
23.36% 24.26% 21.29% 22.19% 19.97% 19.59% 21.17% 22.72% 20.74% 20.99%
Debt/Equity
0.72 0.74 0.62 0.67 0.56 0.57 0.61 0.64 0.58 0.68
Asset Turnover
1.47 1.40 1.43 1.42 1.40 1.39 1.49 1.55 1.54 1.58
Operating CF/Net income
1.63 1.68 1.30 1.30 1.29 1.44 1.33 1.31 1.29 1.40
Capex/Depreciation
(0.83) (0.85) (0.85) (0.82) (0.79) (0.71) (0.76) (0.85) (0.90) (0.83)
Interest Coverage
4.74 8.27 9.97 13.59 14.44 13.47 11.55 12.39 12.82 12.12
ROE
12.16% 14.95% 25.45% 25.71% 24.11% 23.92% 24.12% 23.02% 23.99% 19.52%
ROA
3.97% 5.04% 8.62% 8.79% 8.44% 8.30% 8.49% 8.23% 8.06% 6.00%
ROIC
8.21% 14.26% 16.43% 16.45% 16.02% 16.06% 14.82% 14.54% 15.05% 15.95%
Return on Tangible Assets
(88.95%) (193.69%) (244.15%) (200.40%) (228.49%) (152.87%) (132.51%) (197.82%) (165.85%) (74.08%)
Average Days of Receivables
42.99 44.18 38.28 19.91 35.64 36.06 32.35 29.44 28.72 30.91
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.42 0.44 0.43 0.44 0.40 0.42 0.44 0.45 0.45 0.46
Share Based Compensation of Revenue
0.22% 0.25% 0.28% 0.29% 0.28% 0.26% 0.29% 0.28% 0.30% 0.26%
Graham Net Nets
(0.40) (0.25) (0.20) (0.20) (0.16) (0.23) (0.25) (0.25) (0.24) (0.33)
Graham Number
180.87 192.90 233.62 203.58 179.93 161.15 143.14 124.38 111.61 82.10
Earnings Yield
4.00% 3.06% 4.42% 4.09% 3.60% 4.57% 4.87% 4.89% 4.84% 4.63%
Free Cash Flow Yield
5.36% 4.44% 5.13% 4.82% 4.20% 6.05% 5.86% 5.69% 5.43% 5.26%
Revenue per Share
492.92 434.61 400.45 345.96 304.98 270.96 254.63 234.94 208.67 194.16
Operating CF per Share
21.69 26.28 31.32 27.97 23.69 23.37 19.41 16.32 14.10 10.29
Capex per Share
(3.99) (3.80) (3.65) (2.99) (2.60) (2.16) (2.18) (2.14) (2.10) (1.79)
Free Cash Flow per Share
17.70 22.48 27.67 24.98 21.09 21.20 17.24 14.17 12.01 8.50
Cash per Share
30.97 31.61 31.93 29.79 25.35 20.84 14.98 14.87 16.07 13.94
Shareholders Equity per Share
110.23 106.70 101.75 86.93 79.58 72.00 63.55 56.41 51.69 40.10
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
110.23 106.70 101.75 86.93 79.58 72.00 63.55 56.41 51.69 40.10
Free Cash Flow
16,075.00 20,705.00 25,682.00 23,404.00 19,889.00 20,123.00 16,392.00 13,650.00 11,573.00 8,090.00
Working Capital
(24,315.00) (17,990.00) (20,617.00) (20,168.00) (16,534.00) (18,702.00) (19,148.00) (14,517.00) (13,379.00) (15,373.00)
Capital Expenditures
(3,622.00) (3,499.00) (3,386.00) (2,802.00) (2,454.00) (2,051.00) (2,071.00) (2,063.00) (2,023.00) (1,705.00)
Net Current Asset Value
(118,909.00) (114,231.00) (100,862.00) (95,186.00) (75,403.00) (75,243.00) (70,819.00) (59,210.00) (52,141.00) (50,754.00)
EV/EBIT
18.14 15.77 16.35 18.03 20.53 15.70 15.35 15.00 14.90 12.85
Capex to Sales
0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Price to Operating Income
15.81 14.43 15.47 17.09 19.75 14.85 14.20 13.83 14.02 11.89
Other line items
Depreciation/Fixed assets
0.41 0.39 0.35 0.34 0.35 0.34 0.31 0.29 0.32 0.35
Cash ROIC
8.02% 10.37% 14.09% 14.28% 14.07% 15.88% 14.70% 13.22% 12.29% 10.48%
Accounts Receivable Turnover
8.85 9.16 13.12 14.17 10.75 10.97 12.20 13.28 12.78 12.76
Accounts Payable Turnover
10.08 9.38 9.41 9.34 9.25 9.16 10.34 10.81 10.80 11.16
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
38.07 40.31 41.56 41.37 41.27 43.18 37.59 35.37 35.94 34.48
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
50,584.50 43,712.00 28,325.50 22,881.50 26,743.00 23,433.00 19,856.00 17,040.00 15,740.50 14,487.50
Average Payables
36,184.50 33,147.50 29,836.50 26,179.00 23,569.00 20,750.00 17,855.00 15,942.50 14,270.50 12,677.50
Average Assets
303,929.50 285,999.00 259,712.50 228,955.50 204,747.50 185,589.00 163,055.00 145,639.50 130,934.00 117,032.00
Average Common Equity
99,179.00 96,344.50 87,935.50 78,247.50 71,686.50 64,382.00 57,377.50 52,076.00 44,005.00 35,951.00

Fold the line items

Columns are period end dates